Anti-Adenoviral Effect of Human Argonaute 2 Alone and in Combination with Artificial microRNAs
Cells · 2024
DOI: 10.3390/cells13131117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Philipp Ausserhofer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, IMC University of Applied Sciences Krems, Piaristengasse 1, 3500 Krems, Austria. Hauptthemen laut MEDLINE: Argonaute Proteins, MicroRNAs, Virus Replication, Adenoviruses, Human. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, FWF Austrian Science Fund, Austrian Science Fund.
Abstract (Originalsprache)
During infection, adenoviruses inhibit the cellular RNA interference (RNAi) machinery by saturating the RNA-induced silencing complex (RISC) of the host cells with large amounts of virus-derived microRNAs (mivaRNAs) that bind to the key component of the complex, Argonaute 2 (AGO2). In the present study, we investigated AGO2 as a prominent player at the intersection between human adenovirus 5 (HAdV-5) and host cells because of its ability to interfere with the HAdV-5 life cycle. First, the ectopic expression of AGO2 had a detrimental effect on the ability of the virus to replicate. In addition, in silico and in vitro analyses suggested that endogenous microRNAs (miRNAs), particularly hsa-miR-7-5p, have similar effects. This miRNA was found to be able to target the HAdV-5 DNA polymerase mRNA. The inhibitory effect became more pronounced upon overexpression of AGO2, likely due to elevated AGO2 levels, which abolished the competition between cellular miRNAs and mivaRNAs for RISC incorporation. Collectively, our data suggest that endogenous miRNAs would be capable of significantly inhibiting viral replication if adenoviruses had not developed a mechanism to counteract this function. Eventually, AGO2 overexpression-mediated relief of the RISC-saturating action of mivaRNAs strongly enhanced the effectiveness of artificial miRNAs (amiRNAs) directed against the HAdV-5 preterminal protein (pTP) mRNA, suggesting a substantial benefit of co-expressing amiRNAs and AGO2 in RNAi-based strategies for the therapeutic inhibition of adenoviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biotechnology, IMC University of Applied Sciences Krems, Piaristengasse 1, 3500 Krems, Austria.
- Center for Pathobiochemistry and Genetics, Medical University of Vienna, Währinger Straße 10, 1090 Vienna, Austria.
- Department of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Dr. Bohr-Gasse 9, 1090 Vienna, Austria.
ORCID-Profile: Izabella Kiss, Reinhard Klein
Förderung
- Austrian Science Fund FWF
- FWF Austrian Science Fund
- Austrian Science Fund
Zitieren
APA
Ausserhofer, P., Kiss, I., Witte, A., & Klein, R. (2024). Anti-Adenoviral Effect of Human Argonaute 2 Alone and in Combination with Artificial microRNAs. Cells. https://doi.org/10.3390/cells13131117
Vancouver
Ausserhofer P, Kiss I, Witte A, Klein R. Anti-Adenoviral Effect of Human Argonaute 2 Alone and in Combination with Artificial microRNAs. Cells. 2024. doi:10.3390/cells13131117
BibTeX
@article{Ausserhofer2024,
author = {Ausserhofer, Philipp and Kiss, Izabella and Witte, Angela and Klein, Reinhard},
title = {Anti-Adenoviral Effect of Human Argonaute 2 Alone and in Combination with Artificial microRNAs},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13131117}
}
EUVIMED